HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels

J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):582-9. doi: 10.1097/01.qai.0000214806.90841.c8.

Abstract

Background and aims: The significance of normal alanine aminotransferase (ALT) levels in patients with HIV/hepatitis C virus (HCV) coinfection is not well understood.

Methods: We performed a cross-sectional retrospective analysis on consecutive HIV/HCV-coinfected patients (n = 89) who underwent a liver biopsy during a 2-year period. Similar data were also collected on HCV-monoinfected patients (n = 117).

Results: Mean ALT levels and the percentage of patients with normal ALT (< or =40 U/L) levels were similar in HIV/HCV-coinfected (mean +/- SD, 81.7 +/- 56.1 U/L; 21%) and HCV-monoinfected patients (97.3 +/- 100.7 U/L; 18%; P = 0.19 and 0.54, respectively). Coinfected patients, however, had significantly advanced necroinflammation (P= 0.001) and fibrosis (P = 0.02) compared with monoinfected patients. The percentage of patients with advanced necroinflammation (grades 3 or 4) was lower in HCV-monoinfected patients with normal ALT levels compared with those with elevated ALT (5% vs 20%, respectively). In contrast, the percentage of coinfected patients with advanced necroinflammation was similar whether the patient had normal or elevated ALT levels (32% vs 37%, respectively).

Conclusions: In coinfected patients, normal ALT levels are not an indicator of mild necroinflammation and may not portend a more benign disease course.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alanine Transaminase / blood*
  • Aspartate Aminotransferases / blood
  • Female
  • Genotype
  • HIV Infections / blood
  • HIV Infections / complications*
  • HIV-1 / genetics
  • Hepacivirus / genetics
  • Hepatitis C / blood
  • Hepatitis C / complications*
  • Hepatitis C / epidemiology
  • Humans
  • Inflammation / virology
  • Liver Function Tests
  • Male
  • Middle Aged
  • Racial Groups
  • Reference Values
  • Risk Factors
  • Viral Load

Substances

  • Aspartate Aminotransferases
  • Alanine Transaminase